{"id":13034,"date":"2024-06-20T10:55:52","date_gmt":"2024-06-20T03:55:52","guid":{"rendered":"https:\/\/businessupdate.id\/?p=13034"},"modified":"2024-06-20T10:55:57","modified_gmt":"2024-06-20T03:55:57","slug":"indofarma-catat-rugi-rp605-miliar-sepanjang-2023","status":"publish","type":"post","link":"https:\/\/businessupdate.id\/?p=13034","title":{"rendered":"Indofarma Catat\u00a0 Rugi Rp605 Miliar Sepanjang 2023"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>BusinessUpdate &#8211;<\/strong> PT Indofarma Tbk mencatatkan rugi senilai Rp605 miliar sepanjang 2023. Angka tersebut melonjak 41% secara tahunan (yoy) dibandingkan dengan periode 2022 yang sebesar Rp428 miliar.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Direktur Utama Bio Farma Shadiq Akasya mengungkapkan hal tersebut dalam rapat dengar pendapat bersama Komisi VI DPR RI, Rabu (19\/6\/2024). Ia menjelaskan, kinerja keuangan Indofarma trennya memburuk dari tahun ke tahun, baik dari sisi pendapatan maupun profit.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;<em>Net income<\/em> menurun dari tahun 2022 sebesar negatif (rugi) Rp428 miliar menjadi (rugi) Rp605 miliar di tahun 2023,&#8221; ujar Shadiq. Menurutnya, hal ini dikarenakan adanya penyisihan piutang sebesar Rp46 miliar dan adanya biaya-biaya terkait dengan pajak, kurang lebih sekitar Rp120 miliar.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Begitu pula dengan pendapatan Indofarma yang menurun di 2023 menjadi Rp524 miliar dari tahun sebelumnya mencapai Rp1,14 triliun. Adapun pendapatan tahun lalu ditopang oleh penjualan produk dalam negeri yang mencapai Rp501 miliar.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pendapatan sebelum bunga, pajak, depresiasi, dan amortisasi atau EBITDA juga tercatat negatif, namun mengalami perbaikan. Pada 2023 EBITDA tercatat negatif Rp293 miliar, mengecil dari 2022 yang posisinya negatif Rp361 miliar.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;(Perbaikan) ini disebabkan oleh penurunan beban pemasaran dan distribusi seiring dengan penurunan penjualan dan pelaksanaan efisiensi atas berbagai biaya operasional kantor,&#8221; ungkap Shadiq.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sejalan dengan posisi keuangan yang memburuk, nilai aset Indofarma pun tercatat negatif Rp 615 miliar. Pada 2023 total sebesar Rp933 miliar, menyusut dari tahun sebelumnya yang sebesar Rp1,3 triliun.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sementara itu, posisi ekuitas Indofarma pada 2023 tercatat negatif Rp615 miliar dari sebelumnya Rp86 miliar di 2022. Serta liabilitas tercatat meningkat menjadi Rp1,5 triliun di 2023 dari tahun sebelumnya Rp1,44 triliun.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Shadiq mengakui, persoalan keuangan yang dialami anak usaha Bio Farma itu tak lepas dari laporan Badan Pemeriksa Keuangan (BPK) yang menyoroti kerugian negara atas dugaan fraud atau korupsi di Indofarma sebesar Rp371 miliar.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Menurutnya, sebagai induk usaha, Bio Farma terus berupaya melakukan perbaikan pada Indofarma, terutama dalam menekan beban usaha dan beban keuangan. Bio Farma bahkan membantu dalam hal pendanaan yang bersifat operasional.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Saat ini Indofarma pun sedang menghadapi proses Penundaan Kewajiban Pembayaran Utang (PKPU) seiring dengan permasalahan keuangannya. &#8220;Indofarma saat ini masih dalam proses PKPU, dan proses untuk legal aspeknya masih berjalan seperti yang sekarang,&#8221; tutup Shadiq. (ip\/jh)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BusinessUpdate &#8211; PT Indofarma Tbk mencatatkan rugi senilai Rp605 miliar sepanjang 2023. Angka tersebut melonjak 41% secara tahunan (yoy) dibandingkan dengan periode 2022 yang sebesar Rp428 miliar.&nbsp; Direktur Utama Bio Farma Shadiq Akasya mengungkapkan hal tersebut dalam rapat dengar pendapat bersama Komisi VI DPR RI, Rabu (19\/6\/2024). Ia menjelaskan, kinerja keuangan Indofarma trennya memburuk dari [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":12053,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[81],"tags":[4545,241,3557,3912,6603,7001],"class_list":["post-13034","post","type-post","status-publish","format-standard","has-post-thumbnail","category-bumn","tag-biofarma","tag-bumn","tag-farmasi","tag-fraud","tag-indofarma","tag-kerugian"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.5.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Indofarma Catat\u00a0 Rugi Rp605 Miliar Sepanjang 2023 - Businessupdate.id<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/businessupdate.id\/?p=13034\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Indofarma Catat\u00a0 Rugi Rp605 Miliar Sepanjang 2023 - Businessupdate.id\" \/>\n<meta property=\"og:description\" content=\"BusinessUpdate &#8211; PT Indofarma Tbk mencatatkan rugi senilai Rp605 miliar sepanjang 2023. Angka tersebut melonjak 41% secara tahunan (yoy) dibandingkan dengan periode 2022 yang sebesar Rp428 miliar.&nbsp; Direktur Utama Bio Farma Shadiq Akasya mengungkapkan hal tersebut dalam rapat dengar pendapat bersama Komisi VI DPR RI, Rabu (19\/6\/2024). Ia menjelaskan, kinerja keuangan Indofarma trennya memburuk dari [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/businessupdate.id\/?p=13034\" \/>\n<meta property=\"og:site_name\" content=\"Businessupdate.id\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=100088795961927\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-20T03:55:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-20T03:55:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/businessupdate.id\/wp-content\/uploads\/2024\/04\/indofarma-e1713573151165.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"656\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Iyan Pahlevi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@EnterpriseMse\" \/>\n<meta name=\"twitter:site\" content=\"@EnterpriseMse\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Iyan Pahlevi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/businessupdate.id\/?p=13034\",\"url\":\"https:\/\/businessupdate.id\/?p=13034\",\"name\":\"Indofarma Catat\u00a0 Rugi Rp605 Miliar Sepanjang 2023 - Businessupdate.id\",\"isPartOf\":{\"@id\":\"https:\/\/businessupdate.id\/#website\"},\"datePublished\":\"2024-06-20T03:55:52+00:00\",\"dateModified\":\"2024-06-20T03:55:57+00:00\",\"author\":{\"@id\":\"https:\/\/businessupdate.id\/#\/schema\/person\/9f0dc243b4a81c67b3b44f67a90cfc5d\"},\"breadcrumb\":{\"@id\":\"https:\/\/businessupdate.id\/?p=13034#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/businessupdate.id\/?p=13034\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/businessupdate.id\/?p=13034#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/businessupdate.id\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Indofarma Catat\u00a0 Rugi Rp605 Miliar Sepanjang 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/businessupdate.id\/#website\",\"url\":\"https:\/\/businessupdate.id\/\",\"name\":\"Businessupdate.id\",\"description\":\" \",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/businessupdate.id\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/businessupdate.id\/#\/schema\/person\/9f0dc243b4a81c67b3b44f67a90cfc5d\",\"name\":\"Iyan Pahlevi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/businessupdate.id\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/73245f245eac6c11a32c1359ebe20b0f8067e842bd6d2423ac7dce9a4096ec60?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/73245f245eac6c11a32c1359ebe20b0f8067e842bd6d2423ac7dce9a4096ec60?s=96&d=mm&r=g\",\"caption\":\"Iyan Pahlevi\"},\"url\":\"https:\/\/businessupdate.id\/?author=6\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Indofarma Catat\u00a0 Rugi Rp605 Miliar Sepanjang 2023 - Businessupdate.id","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/businessupdate.id\/?p=13034","og_locale":"en_US","og_type":"article","og_title":"Indofarma Catat\u00a0 Rugi Rp605 Miliar Sepanjang 2023 - Businessupdate.id","og_description":"BusinessUpdate &#8211; PT Indofarma Tbk mencatatkan rugi senilai Rp605 miliar sepanjang 2023. Angka tersebut melonjak 41% secara tahunan (yoy) dibandingkan dengan periode 2022 yang sebesar Rp428 miliar.&nbsp; Direktur Utama Bio Farma Shadiq Akasya mengungkapkan hal tersebut dalam rapat dengar pendapat bersama Komisi VI DPR RI, Rabu (19\/6\/2024). Ia menjelaskan, kinerja keuangan Indofarma trennya memburuk dari [&hellip;]","og_url":"https:\/\/businessupdate.id\/?p=13034","og_site_name":"Businessupdate.id","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=100088795961927","article_published_time":"2024-06-20T03:55:52+00:00","article_modified_time":"2024-06-20T03:55:57+00:00","og_image":[{"width":1280,"height":656,"url":"https:\/\/businessupdate.id\/wp-content\/uploads\/2024\/04\/indofarma-e1713573151165.jpg","type":"image\/jpeg"}],"author":"Iyan Pahlevi","twitter_card":"summary_large_image","twitter_creator":"@EnterpriseMse","twitter_site":"@EnterpriseMse","twitter_misc":{"Written by":"Iyan Pahlevi","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/businessupdate.id\/?p=13034","url":"https:\/\/businessupdate.id\/?p=13034","name":"Indofarma Catat\u00a0 Rugi Rp605 Miliar Sepanjang 2023 - Businessupdate.id","isPartOf":{"@id":"https:\/\/businessupdate.id\/#website"},"datePublished":"2024-06-20T03:55:52+00:00","dateModified":"2024-06-20T03:55:57+00:00","author":{"@id":"https:\/\/businessupdate.id\/#\/schema\/person\/9f0dc243b4a81c67b3b44f67a90cfc5d"},"breadcrumb":{"@id":"https:\/\/businessupdate.id\/?p=13034#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/businessupdate.id\/?p=13034"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/businessupdate.id\/?p=13034#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/businessupdate.id\/"},{"@type":"ListItem","position":2,"name":"Indofarma Catat\u00a0 Rugi Rp605 Miliar Sepanjang 2023"}]},{"@type":"WebSite","@id":"https:\/\/businessupdate.id\/#website","url":"https:\/\/businessupdate.id\/","name":"Businessupdate.id","description":" ","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/businessupdate.id\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/businessupdate.id\/#\/schema\/person\/9f0dc243b4a81c67b3b44f67a90cfc5d","name":"Iyan Pahlevi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/businessupdate.id\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/73245f245eac6c11a32c1359ebe20b0f8067e842bd6d2423ac7dce9a4096ec60?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/73245f245eac6c11a32c1359ebe20b0f8067e842bd6d2423ac7dce9a4096ec60?s=96&d=mm&r=g","caption":"Iyan Pahlevi"},"url":"https:\/\/businessupdate.id\/?author=6"}]}},"_links":{"self":[{"href":"https:\/\/businessupdate.id\/index.php?rest_route=\/wp\/v2\/posts\/13034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/businessupdate.id\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/businessupdate.id\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/businessupdate.id\/index.php?rest_route=\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/businessupdate.id\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13034"}],"version-history":[{"count":1,"href":"https:\/\/businessupdate.id\/index.php?rest_route=\/wp\/v2\/posts\/13034\/revisions"}],"predecessor-version":[{"id":13035,"href":"https:\/\/businessupdate.id\/index.php?rest_route=\/wp\/v2\/posts\/13034\/revisions\/13035"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/businessupdate.id\/index.php?rest_route=\/wp\/v2\/media\/12053"}],"wp:attachment":[{"href":"https:\/\/businessupdate.id\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/businessupdate.id\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/businessupdate.id\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}